A comprehensive survey of staff health and wellbeing at a selection of NHS organisations will map in detail the physical and mental health of NHS staff as well as their perceptions of existing work-wellbeing initiatives and organisational culture.
A research team from RAND Europe and several other organisations are evaluating the role of EU-funded R&D into poverty-related and neglected diseases, in particular examining contributions to achieving universal health coverage and improving population health in low and middle-income countries.
To provide specific and actionable lessons and to help improve the innovation process, its outcomes, and impacts on population health, researchers from RAND Europe and the University of Manchester are exploring the different ways innovation occurs in National Health Service organisations.
Researchers are working to identify options for providing effective medical support to Light Footprint Operations and will define the technology, resources and skill sets necessary to achieve an appropriate level of support.
As part of the global fight against cancer, RAND Europe has led and collaborated on a number of studies exploring the impact of cancer research, the quality of care for cancer patients and the future outlook of different forms of cancer. Our findings and recommendations help inform future research, treatments and ultimately, care for cancer patients.
RAND Europe continues to provide research support to Vitality’s Britain’s Healthiest Workplace. It was commissioned in partnership with the University of Cambridge to help run the competition, which gives awards to organisations for the healthiest employees and work environment. RAND Europe’s role includes designing and running the surveys, analysing results, and providing customised reports to participating organisations. The project’s central aims are to raise awareness and gain a better understanding of how organisations can engage with the wellness of their employees.
An ongoing programme evaluation seeks to assess changes in hospital utilisation by older people in Southwark and Lambeth, following implementation of case management interventions, and whether the additional investment made through the programme has cost more or less than the savings made.
From research on new antimicrobials to surveillance and monitoring of AMR-related issues across the EU, an evaluation of the EU's 2011 Action Plan against AMR will assess both the impacts of the plan and how effectively it was implemented.
A review of clinical and economic evidence, followed by economic modelling, will provide the National Institute for Health Research with a high-quality reference on the clinical and cost-effectiveness of 3 month vs 28 day prescriptions in patients with stable chronic diseases.
RAND Europe, as part of the Cambridge Centre for Health Services Research, is conducting an independent evaluation of telephone triage in general practices, using a mixture of qualitative and quantitative data collection.
RAND Europe is leading a research area within the Addictions and Lifestyles in Contemporary Europe – Reframing Addictions Project, a 5-year EU project to help policymakers rethink approaches to the human and economic costs of addictions by weaving the work of over 150 scientists in 25 countries into an integrated evidence base.
In the current economic climate, there is an increasing need for researchers to demonstrate the benefits resulting from the money invested in research. Ways to do this for social care research are not well established, and RAND Europe has been asked to investigate options including bibliometrics, surveys and economic analysis as part of the wider Social Care Evidence in Practice (SCEiP) project led by the London School of Economics.
RAND Europe’s growing work in the field of mental health and wellbeing draws on expertise from across a range of disciplines and methodological backgrounds to bring an innovative perspective to our projects. In particular, our well-established reputation in healthcare research is complemented by extensive science policy expertise, particularly in the field of research evaluation.
As part of the pan-EU project EPIC-CVD, which aims to provide clinicians and policymakers with a range of evidence-based policy options for cost-effective, individualised risk assessment for cardiovascular disease, researchers are exploring options for the implementation of new cardiovascular risk assessment tools across Europe.
Researchers are evaluating a new model of liaison and diversion (L&D) schemes, which aim to improve early identification of a range of health vulnerabilities among people passing through the UK youth or adult criminal justice system.
To help the Department of Health to determine the value-added and feasibility of social impact bonds, researchers are exploring whether SIBs help achieve better health and social care outcomes, and what the costs and challenges are of using these funding mechanisms.
At a time of reduced public spending there is interest in funding public services on a 'payment by results' basis under which the government pays for services only if and when they achieve defined outcomes. The Department of Health has commissioned a consortium that includes RAND Europe to conduct an independent evaluation of eight drug and alcohol recovery PbR pilots. The research is assessing whether and how the new funding approach encourages the development of the market for provision of services in these areas and more effective recovery programmes.
At the interface between primary care and specialist care, community hospitals have the potential to play a major role in the management of acute and non-acute conditions. RAND Europe is collaborating with the University of Bournemouth to understand how the NHS can advance community hospitals and services in England, learning from comparable hospital models in other countries.
RAND Europe is one of five partners in the Policy Innovation Research Unit (PIRU), which brings together leading health and social care expertise to improve evidence-based policy-making and its implementation across the National Health Service, social care and public health. The Department of Health has funded PIRU with the goal of strengthening early policy development by exploiting the best routine data and by subjecting initiatives to speedy, thorough evaluation.
The improving patient experience in primary care (IMPROVE) programme, a collaboration among RAND Europe, the University of Cambridge, and the University of Exeter, contains seven linked projects. The programme is exploring issues such as how practice teams respond to patient feedback from surveys, how GPs respond to individual patient feedback, use of real time patient feedback in GP practices, and understanding patients’ experiences of out of hours care.
The Public Health Responsibility Deal (RD) aims to bring together public sector, academic, commercial and voluntary organisations in the UK in public-private partnerships to help meet public health goals. Partners pledge to change their services or products in ways that are positive for consumers’ health. RAND Europe is contributing to an evaluation of the RD by examining international examples of similar interventions, from which learning can be drawn for the RD.